Survivorship Promotion In Reducing IGF-1 Trial
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Endometrial Cancer
Related studies linked through entity extraction aliases.
ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?
- Status
- COMPLETED
- Phase
- NA
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Exercise as an Intervention in Endometrial Cancer Survivors
- Status
- UNKNOWN
- Phase
- NA
Hula, a Physical Activity Intervention for Female-Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Lymph Node Counts in Endometrial Cancer Staging
- Status
- COMPLETED
- Phase
- N/A
2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial
- Status
- COMPLETED
- Phase
- NA
DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics
- Status
- RECRUITING
- Phase
- N/A
Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
- Status
- COMPLETED
- Phase
- NA
Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Biomarkers for Gynecologic Cancer
- Status
- UNKNOWN
- Phase
- N/A
Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Indocyanine Green and Near-infrared Fluorescence Imaging to Detect Sentinel Lymph Nodes in Patients With Endometrial Cancer
- Status
- COMPLETED
- Phase
- NA
A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1